Literature DB >> 26201794

Fatty liver score and 15-year incidence of type 2 diabetes.

Anna Kotronen1,2, Maarit A Laaksonen3, Markku Heliövaara4, Antti Reunanen4, Jaakko Tuomilehto5,6,7, Hannele Yki-Järvinen2, Markku Peltonen1, Paul Knekt4.   

Abstract

PURPOSE: Both non-alcoholic fatty liver (NAFL) and alcoholic fatty liver (AFL) are strongly associated with obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). Recently, also the vitamin D level has been associated with these and may also be associated with fatty liver (FL). Liver function tests (LFTs) are insensitive markers of FL, but use of scores may help in identifying subjects with FL. We studied how LFTs and the FL score predict the development of T2DM in subjects with AFL versus NAFL and low versus high vitamin D levels.
METHODS: A cohort study based on 4,517 participants, aged 40-79, from the representative Mini-Finland Health Survey was carried out. During a follow-up of 15 years, 217 T2DM cases occurred. LFTs were determined from serum samples, and the FL score was formed using BMI, fasting glucose, HDL cholesterol, and GGT concentrations.
RESULTS: The risk of T2DM incidence in the highest versus lowest quartile was twofold for the LFTs and ninefold for the FL score. A total of 77 % (95 % confidence interval: 57-87 %) of the T2DM cases could have been prevented if all individuals' FL scores had been at the level of the first quartile. Heavy alcohol consumption and low serum vitamin D concentrations were associated with an increased risk of T2DM among individuals with high FL scores.
CONCLUSIONS: The FL score is a useful tool for diagnosing FL in epidemiological studies. A high FL score predicts increased risk of T2DM, especially when combined with heavy alcohol consumption or low vitamin D levels.

Entities:  

Keywords:  Alcohol consumption; Attributable risk; Cohort studies; Fatty liver score; Liver fat; Liver function test; Type 2 diabetes; Vitamin D

Year:  2013        PMID: 26201794     DOI: 10.1007/s12072-013-9430-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  45 in total

1.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Authors:  Sasiwarang Goya Wannamethee; Andrew Gerald Shaper; Lucy Lennon; Peter H Whincup
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

Review 2.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

3.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Luca Scala; Massimo Cigolini; Luciano Zenari; Giancarlo Falezza; Guido Arcaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-08-22       Impact factor: 4.222

Review 4.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

5.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.

Authors:  Duk Hee Lee; Karri Silventoinen; David R Jacobs; Pekka Jousilahti; Jaakko Tuomileto
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Synergistic effect of fatty liver and smoking on metabolic syndrome.

Authors:  Po-Hsin Chiang; Tsui-Yen Chang; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

7.  The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.

Authors:  A Reunanen; A Aromaa; K Pyörälä; S Punsar; J Maatela; P Knekt
Journal:  Acta Med Scand Suppl       Date:  1983

8.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Authors:  Elmar Aigner; Igor Theurl; Milan Theurl; Dieter Lederer; Heike Haufe; Otto Dietze; Michael Strasser; Christian Datz; Guenter Weiss
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

9.  Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.

Authors:  Wolfram Goessling; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino; R Curtis Ellison; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

Review 10.  Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.

Authors:  Hima Boppidi; Sumanth R Daram
Journal:  Postgrad Med       Date:  2008-07-31       Impact factor: 3.840

View more
  3 in total

Review 1.  Non-alcoholic fatty liver disease and diabetes.

Authors:  Jonathan M Hazlehurst; Conor Woods; Thomas Marjot; Jeremy F Cobbold; Jeremy W Tomlinson
Journal:  Metabolism       Date:  2016-01-11       Impact factor: 8.694

2.  Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women.

Authors:  Yoshiharu Tokita; Yuko Maejima; Kenju Shimomura; Seiichi Takenoshita; Nobuyoshi Ishiyama; Masako Akuzawa; Yohnosuke Shimomura; Katsuyuki Nakajima
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

Review 3.  Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Vittoria Zambon Azevedo; Cristina Alina Silaghi; Thomas Maurel; Horatiu Silaghi; Vlad Ratziu; Raluca Pais
Journal:  Front Nutr       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.